1. Home
  2. INSG vs AARD Comparison

INSG vs AARD Comparison

Compare INSG & AARD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Inseego Corp.

INSG

Inseego Corp.

HOLD

Current Price

$6.64

Market Cap

144.4M

ML Signal

HOLD

Logo Aardvark Therapeutics Inc.

AARD

Aardvark Therapeutics Inc.

HOLD

Current Price

$6.31

Market Cap

165.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
INSG
AARD
Founded
1996
2017
Country
United States
United States
Employees
N/A
40
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
144.4M
165.8M
IPO Year
2000
N/A

Fundamental Metrics

Financial Performance
Metric
INSG
AARD
Price
$6.64
$6.31
Analyst Decision
Buy
Buy
Analyst Count
3
9
Target Price
$15.33
$15.29
AVG Volume (30 Days)
241.9K
439.4K
Earning Date
05-07-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.65
N/A
Revenue
$313,832,000.00
N/A
Revenue This Year
$16.21
N/A
Revenue Next Year
$13.28
N/A
P/E Ratio
$10.89
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.28
$3.35
52 Week High
$21.90
$17.94

Technical Indicators

Market Signals
Indicator
INSG
AARD
Relative Strength Index (RSI) 23.12 56.27
Support Level N/A $4.76
Resistance Level $12.95 $7.92
Average True Range (ATR) 0.45 0.92
MACD -0.01 -0.01
Stochastic Oscillator 0.45 50.55

Price Performance

Historical Comparison
INSG
AARD

About INSG Inseego Corp.

Inseego Corp is involved in the design and development of fixed and mobile wireless solutions (4G and 5G NR), Industrial Internet of Things, and cloud solutions for enterprises, service providers, small and medium-sized businesses, governments, and consumers around the globe. Its products and services include intelligent mobile hotspots, wireless routers for IoT applications, USB modems, integrated telematics and mobile tracking devices, which are supported by application software and cloud services designed to enable customers to analyze data insights and configure and manage their hardware easily. It generates maximum revenue from the United States and Canada. The company also has a presence in Europe (including the United Kingdom).

About AARD Aardvark Therapeutics Inc.

Aardvark Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. It is focused on on developing selective compounds, targeting Bitter Taste Receptors (TAS2Rs) for hunger-associated conditions. Its product candidate, ARD-101, is an oral gut-restricted small-molecule agonist of certain TAS2Rs expressed in the gut lumen for which have initiated a Phase 3 clinical trial for hyperphagia associated with PWS.

Share on Social Networks: